Ovarian suppression was recently suggested as an inherent feature of effective zona pellucida (ZP) based immunocontraception across various species including horses. Measuring anti-Müllerian hormone (AMH) in immunocontracepted mares may provide a novel and minimally-invasive tool for the assessment of ovarian function (Joone et al, Theriogenology, 2018, vol. 106(2): 214-220). This study aimed to assess the utility of measuring serum AMH concentrations by comparison with clinical parameters for monitoring ovarian activity following ZP-based immunocontraception in a population of horse mares.
Reference:
Nolan, M.B. et al. 2018. Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. Journal of Equine Veterinary Science, vol. 66(105): 1pp
Nolan, M., Bertschinger, H., Crampton, M., & Schulman, M. (2018). Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. http://hdl.handle.net/10204/10463
Nolan, MB, HJ Bertschinger, Michael Crampton, and ML Schulman "Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares." (2018) http://hdl.handle.net/10204/10463
Nolan M, Bertschinger H, Crampton M, Schulman M. Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. 2018; http://hdl.handle.net/10204/10463.
Copyright: 2018 Elsevier. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website.
ResearchSpace
